These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The duration of fetal antenatal steroid exposure determines the durability of preterm ovine lung maturation. Kemp MW; Saito M; Schmidt AF; Usuda H; Watanabe S; Sato S; Hanita T; Kumagai Y; Takahashi T; Musk GC; Furfaro L; Stinson L; Fee EL; Eddershaw PJ; Payne MS; Smallwood K; Bridges J; Newnham JP; Jobe AH Am J Obstet Gynecol; 2020 Feb; 222(2):183.e1-183.e9. PubMed ID: 31494126 [TBL] [Abstract][Full Text] [Related]
7. Variability in the efficacy of a standardized antenatal steroid treatment was independent of maternal or fetal plasma drug levels: evidence from a sheep model of pregnancy. Takahashi T; Saito M; Schmidt AF; Usuda H; Takahashi Y; Watanabe S; Hanita T; Sato S; Kumagai Y; Koshinami S; Ikeda H; Carter S; Clarke M; Fee EL; Yaegashi N; Newnham JP; Jobe AH; Kemp MW Am J Obstet Gynecol; 2020 Dec; 223(6):921.e1-921.e10. PubMed ID: 32445634 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. Jobe AH; Milad MA; Peppard T; Jusko WJ Clin Transl Sci; 2020 Mar; 13(2):391-399. PubMed ID: 31808984 [TBL] [Abstract][Full Text] [Related]
9. Betamethasone phosphate reduces the efficacy of antenatal steroid therapy and is associated with lower birthweights when administered to pregnant sheep in combination with betamethasone acetate. Takahashi T; Fee EL; Takahashi Y; Saito M; Yaegashi N; Usuda H; Furfaro L; Carter S; Schmidt AF; Newnham JP; Jobe AH; Kemp MW Am J Obstet Gynecol; 2022 Apr; 226(4):564.e1-564.e14. PubMed ID: 34626553 [TBL] [Abstract][Full Text] [Related]
10. Low-dose antenatal betamethasone treatment achieves preterm lung maturation equivalent to that of the World Health Organization dexamethasone regimen but with reduced endocrine disruption in a sheep model of pregnancy. Usuda H; Fee EL; Carter S; Furfaro L; Takahashi T; Takahashi Y; Newnham JP; Milad MA; Saito M; Jobe AH; Kemp MW Am J Obstet Gynecol; 2022 Dec; 227(6):903.e1-903.e16. PubMed ID: 35792176 [TBL] [Abstract][Full Text] [Related]
11. Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome. Anoshchenko O; Milad MA; Unadkat JD CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1057-1070. PubMed ID: 34273255 [TBL] [Abstract][Full Text] [Related]
12. Maternofetal pharmacokinetics and fetal lung responses in chronically catheterized sheep receiving constant, low-dose infusions of betamethasone phosphate. Kemp MW; Saito M; Usuda H; Molloy TJ; Miura Y; Sato S; Watanabe S; Clarke M; Fossler M; Scmidt A; Kallapur SG; Kramer BW; Newnham JP; Jobe AH Am J Obstet Gynecol; 2016 Dec; 215(6):775.e1-775.e12. PubMed ID: 27555319 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of betamethasone and fetal cardiovascular adverse effects in pregnant sheep after different doses. Schwab M; Coksaygan T; Samtani MN; Jusko WJ; Nathanielsz PW Obstet Gynecol; 2006 Sep; 108(3 Pt 1):617-25. PubMed ID: 16946223 [TBL] [Abstract][Full Text] [Related]
14. Betamethasone dose and formulation for induced lung maturation in fetal sheep. Jobe AH; Nitsos I; Pillow JJ; Polglase GR; Kallapur SG; Newnham JP Am J Obstet Gynecol; 2009 Dec; 201(6):611.e1-7. PubMed ID: 19800603 [TBL] [Abstract][Full Text] [Related]
15. Betamethasone for lung maturation: testing dose and formulation in fetal sheep. Jobe AH; Moss TJ; Nitsos I; Ikegami M; Kallapur SG; Newnham JP Am J Obstet Gynecol; 2007 Nov; 197(5):523.e1-6. PubMed ID: 17980195 [TBL] [Abstract][Full Text] [Related]
16. Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids. Jobe AH; Newnham J; Willet K; Sly P; Ikegami M Pediatrics; 1998 Nov; 102(5):1116-25. PubMed ID: 9794943 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Maternal Drug Exposure Following the Administration of Antenatal Corticosteroids During Late Pregnancy Using Physiologically-Based Pharmacokinetic Modeling. Ke AB; Milad MA Clin Pharmacol Ther; 2019 Jul; 106(1):164-173. PubMed ID: 30924921 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacodynamic modeling of intramuscular and oral dexamethasone and betamethasone effects on six biomarkers with circadian complexities in Indian women. Krzyzanski W; Milad MA; Jobe AH; Peppard T; Bies RR; Jusko WJ J Pharmacokinet Pharmacodyn; 2021 Jun; 48(3):411-438. PubMed ID: 33954911 [TBL] [Abstract][Full Text] [Related]
19. Area/moment and compartmental modeling of pharmacokinetics during pregnancy: applications to maternal/fetal exposures to corticosteroids in sheep and rats. Samtani MN; Schwab M; Nathanielsz PW; Jusko WJ Pharm Res; 2004 Dec; 21(12):2279-92. PubMed ID: 15648260 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of betamethasone and dexamethasone fetal administration of parturition in sheep. Derks JB; Giussani DA; Van Dam LM; Jenkins SL; Winter JA; Zhao XF; Hammond GL; Nathanielsz PW J Soc Gynecol Investig; 1996; 3(6):336-41. PubMed ID: 8923418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]